+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ablynx - logo

Ablynx NV, a biopharmaceutical company, develops Nanobodies that is a proprietary therapeutic protein based on single-domain antibody fragments for the treatment of various diseases. The company develops products in various therapeutic areas, such as inflammation, hematology, oncology, and respiratory diseases. The company was formerly known as MatchX and changed its name to Ablynx NV in June 2002. Ablynx NV was founded in 2001 and is headquartered in Ghent, Belgium.

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025 - Product Thumbnail Image

Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2019-2025

  • Report
  • April 2025
  • 750 Pages
  • Global
From
Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of End User and Key Geographies: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Synthetic Biology: Protein Design and Engineering Market by Type of Protein Engineering Approach Used, Type of Protein, Type of Application, Type of End User and Key Geographies: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • January 2022
  • 242 Pages
  • Global
From
Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Thrombotic Thrombocytopenic Purpura (Moschcowitz Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 51 Pages
  • Global
From
Nebulizer Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Thumbnail Image

Nebulizer Systems Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • July 2024
  • 70 Pages
  • Global
From
Osteoporosis - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoporosis - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 375 Pages
  • Global
From
Bone Metastases - Pipeline Insight, 2024 - Product Thumbnail Image

Bone Metastases - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Thrombotic thrombocytopenic purpura - Pipeline Insight, 2024 - Product Thumbnail Image

Thrombotic thrombocytopenic purpura - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Human Respiratory Syncytial Virus Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type - Product Thumbnail Image

Human Respiratory Syncytial Virus Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Product Type

  • Report
  • October 2024
  • 92 Pages
  • Global
From
Respiratory Syncytial Virus Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Respiratory Syncytial Virus Drugs Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • August 2024
  • 108 Pages
  • Global
From
Thrombocytopenia - Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Thrombocytopenia - Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • September 2022
  • 225 Pages
  • Global
From
US Thrombotic Thrombocytopenic Purpura (TTP) Market Insight, Epidemiology and Market Forecast -2030 - Product Thumbnail Image

US Thrombotic Thrombocytopenic Purpura (TTP) Market Insight, Epidemiology and Market Forecast -2030

  • Report
  • October 2021
  • 110 Pages
  • United States
From
IL-6 Receptor Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

IL-6 Receptor Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028 - Product Thumbnail Image

Rybrevant Bispecific Antibody Patent, Sales & Clinical Trials Outlook 2028

  • Report
  • October 2021
  • 78 Pages
  • Global
From
Global Proteomics Partnering Terms and Agreements 2010 to 2023 - Product Thumbnail Image

Global Proteomics Partnering Terms and Agreements 2010 to 2023

  • Report
  • June 2023
  • 400 Pages
  • Global
From
Royalty Rates in Pharmaceutical and Biotechnology Deals 2010-2025 - Product Thumbnail Image

Royalty Rates in Pharmaceutical and Biotechnology Deals 2010-2025

  • Report
  • April 2025
  • 500 Pages
  • Global
From
Osteoarthritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Osteoarthritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 384 Pages
  • Global
From
Biopharmaceuticals - A Global Market Overview - Product Thumbnail Image

Biopharmaceuticals - A Global Market Overview

  • Report
  • February 2025
  • 225 Pages
  • Global
From
Regenerative Medicine Collaboration and Licensing Deals 2019-2024 - Product Thumbnail Image

Regenerative Medicine Collaboration and Licensing Deals 2019-2024

  • Report
  • November 2024
  • 700 Pages
  • Global
From
Gene Therapy Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
Bone Metastasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bone Metastasis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • August 2022
  • 98 Pages
  • Global
From
Loading Indicator